Both p16 and p21 Families of Cyclin-dependent Kinase (CDK) Inhibitors Block the Phosphorylation of Cyclin-dependent Kinases by the CDK-activating Kinase (*)

  1. Olga Aprelikova(1)(4),
  2. Yue Xiong(4)(2)(3) and
  3. Edison T. Liu(1)(4)(3)(§)
  1. From the (1) Departments of Medicine and
  2. (2) Biochemistry and Biophysics, the
  3. (3) Curriculum in Genetics and Molecular Biology, and the
  4. (4) Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7295
  1. § Leukemia Society Scholar. To whom correspondence should be addressed:
    CB 7295, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599.
    Tel.: 919-966-1352; Fax: 919-966-3015; medetl{at}med.unc.edu

Abstract

Phosphorylation of cyclin-dependent kinases (CDKs) by the CDK-activating kinase is required for the activation of CDK enzymes. Members of two families of CDK inhibitors, p16/p18 and p21/p27, become physically associated with and inhibit the activity of CDKs in response to a variety of growth-modulating signals. Here, we show that the representative members of both families of CDK inhibitors, p21Graphic, p27Graphic, and p18, can prevent the phosphorylation of their CDK partners, CDK2 and CDK6, by CDK-activating kinase. No direct interaction between CDK-activating kinase and the CDK inhibitors could be detected, suggesting that binding of these CDK inhibitors to CDK subunits renders CDK inaccessible to the CDK-activating kinase phosphorylation. These findings suggest that a general mechanism of CDK inhibitor function is to block the phosphorylation of CDK enzymes by CDK-activating kinase.

Footnotes

  • * This work was supported by Grant P50-CA-58223 from the National Institutes of Health, NCI (SPORE in breast cancer, to E. T. L., Y. X., and O. A.), and start-up funds from the University of North Carolina at Chapel Hill (to Y. X.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    CDK

    cyclin-dependent kinase

    CAK

    CDK-activating kinase

    PCR

    polymerase chain reaction

    GST

    glutathione S-transferase.

  • 2K. L. Guan, C. W. Jenkins, Y. Li, M. Zariwala, S. Noh, X. Wu, and Y. Xiong, submitted for publication.

  • 3D. R. Mayrose, M. A. Nichols, Y. Xiong, and H. Ke, submitted for publication.

    • Received April 5, 1995.
    • Revision received May 5, 1995.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement